Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies
A Prospective Study Evaluating Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies
M.D. Anderson Cancer Center
170 participants
Apr 8, 2019
OBSERVATIONAL
Conditions
Summary
This study collects information about complications and clinical response in cancer patients treated with anti-VEGF-related therapies. This study aims to observe side effects that may happen to patients with advanced cancer who are treated with anti-VEGF related therapy. This may help doctors learn if there are any relationships between these side effects and how the disease may respond to treatment.
Eligibility
Inclusion Criteria2
- Patients must be able to understand and be willing to sign a written informed consent document
- Patients must be receiving any anti-VEGF-related regimen in monotherapy or combination therapy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Medical records are reviewed
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05108519